IL90391A0 - Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them - Google Patents

Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL90391A0
IL90391A0 IL90391A IL9039189A IL90391A0 IL 90391 A0 IL90391 A0 IL 90391A0 IL 90391 A IL90391 A IL 90391A IL 9039189 A IL9039189 A IL 9039189A IL 90391 A0 IL90391 A0 IL 90391A0
Authority
IL
Israel
Prior art keywords
immune system
preparation
function
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL90391A
Other languages
English (en)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL90391A0 publication Critical patent/IL90391A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL90391A 1988-06-14 1989-05-23 Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them IL90391A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU883037A HU201095B (en) 1988-06-14 1988-06-14 New peptides inhibiting the activity of the immune system and pharmaceutical compositions comprising same, as well as process for producing these peptides and compositions

Publications (1)

Publication Number Publication Date
IL90391A0 true IL90391A0 (en) 1990-01-18

Family

ID=10962229

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90391A IL90391A0 (en) 1988-06-14 1989-05-23 Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US5008246A (de)
EP (1) EP0348086B1 (de)
JP (1) JPH0778075B2 (de)
CN (1) CN1038817A (de)
AT (1) ATE119914T1 (de)
AU (1) AU620406B2 (de)
CA (1) CA1327867C (de)
DE (1) DE68921674T2 (de)
DK (1) DK288789A (de)
ES (1) ES2068893T3 (de)
GR (1) GR3015890T3 (de)
HU (1) HU201095B (de)
IL (1) IL90391A0 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003180A1 (en) * 1988-09-30 1990-04-05 Immunobiology Research Institute, Inc. Peptides having t cell suppressor activity
EP0445606B1 (de) * 1990-02-27 1997-01-22 The Agency of Industrial Science and Technology Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
CA2144514C (en) 1992-09-16 2002-03-26 Thangavel Kuberasampath Morphogen-induced liver regeneration
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
RU2107691C1 (ru) 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US6159940A (en) * 1996-02-28 2000-12-12 Immunotech Developments Inc. Method for modulating hemopoiesis
EP0894004B2 (de) 1996-03-22 2007-02-21 Curis, Inc. Verfahren zur verbesserten funktionelle erholung der motorische koordiination, der sprache oder der sinneswahrnehmung nach trauma oder isch?mie des zns
BR9809641A (pt) * 1997-05-17 2000-07-11 Biogen Inc Uso de um interruptor de ligação cd40:cd154 para evitar respostas imunes inadaptadas, particularmente rejeição a enxerto
EP1754490A3 (de) 1997-06-20 2010-01-20 Biogen Idec MA Inc. CD154-Blockadetherapie der Pankreasinselzellentransplantation bei Primaten
CN1927879B (zh) * 2006-09-25 2010-11-24 吉林大学 胸腺五肽活性异构体及其在药物制备中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
EP0215805A1 (de) * 1985-01-18 1987-04-01 MERCK PATENT GmbH Immunoregulatorische peptide
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity

Also Published As

Publication number Publication date
CA1327867C (en) 1994-03-15
DK288789D0 (da) 1989-06-13
DE68921674D1 (de) 1995-04-20
ATE119914T1 (de) 1995-04-15
HU201095B (en) 1990-09-28
GR3015890T3 (en) 1995-07-31
CN1038817A (zh) 1990-01-17
EP0348086A3 (en) 1990-09-12
JPH0232095A (ja) 1990-02-01
AU3629389A (en) 1990-01-04
EP0348086A2 (de) 1989-12-27
US5008246A (en) 1991-04-16
HUT50195A (en) 1989-12-28
ES2068893T3 (es) 1995-05-01
AU620406B2 (en) 1992-02-20
DK288789A (da) 1989-12-15
DE68921674T2 (de) 1995-08-03
EP0348086B1 (de) 1995-03-15
JPH0778075B2 (ja) 1995-08-23

Similar Documents

Publication Publication Date Title
EP2145897A3 (de) Therapeutische Verfahren und Zusammensetzungen basierend auf Serrate-Proteinen und Nukleinsäuren
AU561343B2 (en) Human immune interferon by recombinant dna
ES8801674A1 (es) Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
AU6819294A (en) Oral drug delivery compositions and methods
EP0210189A4 (de) Rekombinantes alveolares oberflächenaktives protein.
DE3873397D1 (de) Bifunktionelle proteine.
IL90391A0 (en) Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them
CA2042016A1 (en) Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
IL90356A0 (en) Amphiphilic peptides and pharmaceutical compositions containing them
FI93843C (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
IE890087L (en) Recombinant human interleukin-1 alpha polypeptides
CA2089111A1 (en) Smooth muscle mitogen and isolated dna coding therefor
EP0723016A3 (de) Leukocyten-aktivierender Faktor
EP0341661A3 (de) Alpha-Aminoborsäure-Derivate enthaltende Peptid-Mittel Zusammensetzungen
ATE79638T1 (de) Polypeptide, deren kodierende peptide und methode zur herstellung dieser peptide und dnas.
EP0342015A3 (de) Peptide, deren Benutzung und sie enthaltende pharmazeutische Zusammensetzungen
IL96513A (en) Dna encoding for a polypeptide comprising the amino acid sequence of des-cys-tyr-cys recombinant human immune interferon,producing such a polypeptide and pharmaceutical compositions comprising it
CA2311684A1 (en) Chemically-modified g-csf
IL96513A0 (en) Polypeptide comprising the amino acid sequence of recombinant human immune interferon